Tacrolimus(Prograf,Astellas Pharma Europe Ltd,Staines,United Kingdom;referred to as tacrolimus-BID)is an immunosuppressive agent to prevent and treat allograft
AIM To evaluate use of palliative care services in patients with end-stage liver disease who do not have access to liver transplant.METHODS Evaluated were end-s
AIM To characterize major determinants of 20-year survival after liver transplantation(LT).METHODS This longitudinal single-institution study includes 313 conse
AIM:To determine the general and transplant-specific risk factors for fractures in kidney transplant recipients.METHODS:We conducted a cohort study of all adult